Accentia Biopharmaceuticals Inc (1310094) SEC Filing 10-K Annual report for the fiscal year ending Friday, September 30, 2011

Accentia Biopharmaceuticals Inc

CIK: 1310094
Document And Entity Information (USD $)
12 Months Ended
Sep. 30, 2011
Dec. 15, 2011
Mar. 31, 2011
Document And Entity Information [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Period End Date Sep. 30, 2011    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2011    
Entity Central Index Key 0001310094    
Current Fiscal Year End Date --09-30    
Entity Filer Category Smaller Reporting Company    
Entity Common Stock, Shares Outstanding   75,238,376  
Entity Well-known Seasoned Issuer No    
Entity Public Float     $ 30,662,663
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    

View differences made from one year to another to evaluate Accentia Biopharmaceuticals Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Accentia Biopharmaceuticals Inc.


Assess how Accentia Biopharmaceuticals Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Accentia Biopharmaceuticals Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2011 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
CIK: 1310094
Form Type: 10-K Annual Report
Accession Number: 0001193125-11-345824
Submitted to the SEC: Mon Dec 19 2011 5:15:02 PM EST
Accepted by the SEC: Mon Dec 19 2011
Period: Friday, September 30, 2011
Industry: Pharmaceutical Preparations

External Resources:

Bookmark the Permalink: